Skip to main content

Investor and Venator in war of words

15th January 2023

Submitted by:

Andrew Warmington

Czech Republic-based J&T MS 1 SICAV has sent a public letter to the board of TiO2 producer Venator Materials highly critical of the firm’s strategic direction and demanding additional independent shareholder representation. J&T is the second largest shareholder in Venator, with a stake of 14.3%.

Since an IPO in August 2017, the letter states, Venator’s share price has fallen by about 96% from a peak of $25.50 to less than $1. In November 2022, the company was warned that it faces a potential delisting from the New York Stock Exchange.

“Despite this drastic decline, we believe the company has failed to articulate a go-forward strategy to restore confidence among investors and, consequently, the stock has continued to languish,” J&T said. “Frankly, in our view, Venator is by far the worst financially performing TiO2 producer – and one of the worst in the entire chemical sector.”

J&T added that it is not an ‘activist’ shareholder and does not generally do not go public with such concerns. “However, after trying to reach a resolution privately for seven months and being met with apparent delay tactics and gamesmanship, we believe we have no other recourse.”

In May 2022, J&T said, it reached out to the company proposing its portfolio manager Martin Seycek as a board observer, then, when this refused as a member. However, Venator had been obstructive in its attitude and the ostensibly independent directors it subsequently appointed were not truly independent of the main shareholder, SK Capital, which acquired a 40% stake from Huntsman in December 2020.

In addition, and unlike its peers Tronox and Chemours, Venator does not have any directors from outside the chemical industry, the letter continued. For this reason, J&T concluded, “shareholder-driven change is desperately needed to bring fresh perspectives and credibility to the board”.

In response, Venator said: “We maintain a regular and open dialogue with our shareholders and welcome their input.” Management had been seeking to hold discussions with J&T for several months and recently scheduled a meeting with them. “Beyond its demand for board seats, J&T has yet to offer any concrete thesis or recommendations.”

The company added that it is “navigating unprecedented headwinds of macroeconomic uncertainty, low consumer confidence, weak demand, record high energy prices and other inflationary costs”. In response, it has taken such actions as implementing a $50 million cost reduction programme, closing a $51 million sale-leaseback transaction for a site in its Color Pigments business and sold the iron oxide business for an enterprise value of $140 million.

Subsequently, in a Q4 business update, Venator announced that it appointed both Moelis & Company and Kirkland & Ellis, in addition to business and operational advisor Alvarez & Marsal “to assist with strategic review and engagement with stakeholders”. It also named two new independent directors to replace two outgoing directors.

Stefan M. Selig will be chairman, Barry Siadat of SK having stepped down, and will join the audit committee. Selig is the founder of BridgePark Advisors and a board member at both Safehold and Simon Property Group, was also formerly Undersecretary of Commerce for International Trade for the US Department of Commerce from 2014 to 2016.

Meanwhile Jame Donath joined following the resignation of Miguel Kohlmann and will be on the compensation committee. He has had a 20-year plus career in private equity and was formerly managing partner of Magnolia Road Capital.

Venator said that it expects Q4 TiO2 sales volumes to be around 28% lower than Q3 and 44% lower than Q4 2021, leading to a negative projected EBITDA of $57-62 million. This was blamed on challenging macro-economic conditions, including low consumer confidence, weak demand, record high energy prices and other inflationary costs.

“These factors are particularly acute in Europe, where the majority of our business is located,” stated Simon Turner, president and CEO. “We have been working hard to address these headwinds and have already taken proactive steps to ensure we are managing all factors that are within our control by continuing to improve the overall operations of the business

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington